© 2021 MJH Life Sciences and Pharmacy Times. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmacy Times. All rights reserved.
June 24, 2021
Individuals with diabetes, and other related underlying health conditions, are being hospitalized 6 times more often and are 12 times more likely to die of COVID-19 than those without diabetes.
June 17, 2020
According to a recent study presented at the ADA’s 80th Scientific Sessions, youth and young adults with type 1 diabetes (T1D) in the United States today have worse glycemic control than prior generations.
Treatment of recently diagnosed patients with type 1 diabetes (T1D) with anti-IL-21 and liraglutide for 54 weeks was found to be safe and resulted in sustained insulin secretion and lower insulin dose.
June 16, 2020
The DPPOS is the long-term follow-up of the Diabetes Prevention Program (DPP), a multicenter trial conducted from 1996 to 2001 that established the success of either an intensive lifestyle program or treatment with metformin to prevent or delay the development of T2D in individuals who were considered at high risk for developing the disease.
Oral insulin (OI) slows insulin decline in those at high risk for type 1 diabetes (T1D), according to a poster session at the American Diabetes Association’s 80th virtual Scientific Sessions.
There have not been many evaluations of the prevalence of, and factors associated with, use of DSME/S and support programs in newly diagnosed patients with type 2 diabetes (T2D) in Louisiana, according to the study authors.
The slowed metabolic decline among the OI trial participants at highest risk was assessed and defined by the DPT1 Risk Scores over a 6.75 threshold.
The TEDDY study also aims to identify environmental triggers that cause the immune destruction of beta cells.
June 15, 2020
The results of the study demonstrated that dapagliflozin was able to reduce new-onset diabetes by 32%.
The results of the real-world, observational study were presented by Eli Lilly during the American Diabetes Association's 80th Virtual Scientific Sessions.